Barry E. Greene, President at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 85,316 shares at $125.00 ($10.7M) on 2017-10-02, disclosed to the SEC on 2017-10-04.
Open-market sale of $10.7M ALNY by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SAGE | BUY | 2021-06-17 | $496K | — | Filing → |
| ALNY | SELL | 2020-09-11 | $11.0M | — | Filing → |
| ALNY | SELL | 2020-07-09 | $7.1M | — | Filing → |